Effect of Vasopressin on Hemodynamics in Patients with Refractory Cardiogenic Shock Complicating Acute Myocardial Infarction
Overview
Authors
Affiliations
In a retrospective study of 36 patients who developed cardiogenic shock after myocardial infarction, intravenous vasopressin therapy increased mean arterial pressure from 56 to 73 mm Hg at 1 hour (p < 0.001) and maintained it for 24 hours without changing pulmonary capillary wedge pressure, cardiac index, urine output, or other inotropic requirements. After norepinephrine administration, mean pulmonary capillary wedge pressure increased at 1 hour from 21 to 24 mm Hg (p = 0.04); however, this increase was not sustained at 12 and 24 hours. Norepinephrine was associated with a significant increase in cardiac power index at 24 hours, whereas there was only a trend for an increase in cardiac power with vasopressin therapy. In a cohort of patients who developed refractory cardiogenic shock after myocardial infarction, vasopressin was associated with increased mean arterial pressure and no adverse effect on other hemodynamic parameters.
Ortega-Hernandez J, Gonzalez-Pacheco H, Araiza-Garaygordobil D, Gopar-Nieto R, Sierra-Lara-Martinez D, Manzur-Sandoval D Front Cardiovasc Med. 2025; 12:1461714.
PMID: 40017516 PMC: 11865078. DOI: 10.3389/fcvm.2025.1461714.
Mixed Cardiogenic-Vasodilatory Shock: Current Insights and Future Directions.
Jentzer J, Berg D, Chonde M, Dahiya G, Elliott A, Rampersad P JACC Adv. 2024; 4(1):101432.
PMID: 39720581 PMC: 11666941. DOI: 10.1016/j.jacadv.2024.101432.
State of Shock: Contemporary Vasopressor and Inotrope Use in Cardiogenic Shock.
Bloom J, Chan W, Kaye D, Stub D J Am Heart Assoc. 2023; 12(15):e029787.
PMID: 37489740 PMC: 10492962. DOI: 10.1161/JAHA.123.029787.
The medical treatment of cardiogenic shock.
Lescroart M, Pequignot B, Janah D, Levy B J Intensive Med. 2023; 3(2):114-123.
PMID: 37188116 PMC: 10175741. DOI: 10.1016/j.jointm.2022.12.001.
Early Recognition and Risk Stratification in Cardiogenic Shock: Well Begun Is Half Done.
Polyzogopoulou E, Bezati S, Karamasis G, Boultadakis A, Parissis J J Clin Med. 2023; 12(7).
PMID: 37048727 PMC: 10095596. DOI: 10.3390/jcm12072643.